Subcutaneous and intravenous delivery of diagnostic agents to the lymphatic system: Applications in lymphoscintigraphy and indirect lymphography

Advanced Drug Delivery Reviews

Volumn 37, Issue 1-3, 1999, Pages 295-312

  Moghimi, S M ^a   Bonnemain, B ^b  

^a UNIVERSITY OF BRIGHTON   (United Kingdom)

^b Laboratoire Guerbet   (France)

Author keywords

Computer tomography; Contrast agents; Gamma scintigraphy; Imaging; Lymph nodes; Lymphatic system; Lymphography; Macrophage; Magnetic resonance; Positron emission tomography; Radiopharmaceuticals; Superparamagnetic iron oxide particles

Indexed keywords

CELLS; COLLOIDS; COMPUTERIZED TOMOGRAPHY; CONTRAST MEDIA; DIAGNOSTIC RADIOGRAPHY; DRUG PRODUCTS; IRON OXIDES; MACROMOLECULES; MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; RADIOISOTOPES;

GAMMA SCINTIGRAPHY; INDIRECT LYMPHOGRAPHY; LYMPH NODES; LYMPHATIC SYSTEM; LYMPHOSCINTIGRAPHY; MACROPHAGES; NEOPLASTIC CELL; RADIOPHARMACEUTICALS; SINGLE INTRAVENOUS INJECTION; SUPERPARAMAGNETIC IRON OXIDE PARTICLES;

CONTROLLED DRUG DELIVERY;

ANTIMONY TECHNETIUM SULFIDE TC 99M; CONTRAST MEDIUM; DEXTRAN TC 99M; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE; HUMAN SERUM ALBUMIN TC 99M; INDIUM 111; IODINE 125; IODINE 131; IOTROLAN; IRON OXIDE; MACROGOL; MONOCLONAL ANTIBODY I 125; MONOCLONAL ANTIBODY I 131; POLYMER; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M;

BIOPSY; CANCER DIAGNOSIS; CANCER STAGING; COLLOID; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; GAMMA SCINTIGRAPHY; HISTOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHANGIOGRAPHY; LYMPHATIC SYSTEM; LYMPHOGRAPHY; LYMPHOSCINTIGRAPHY; MACROMOLECULE; MACROPHAGE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0344609236     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(98)00099-4     Document Type: Review

References (115)

1. H.L. Abrams, R. Spiro, N. Goldstein, Metastases in carcinoma: analysis of 1000 autopsied cases, Cancer 3 (1950) 74-85.
2. M.S. Didolkar, N. Fanous, E.G. Elias, R.H. Moore, Metastatic carcinomas from occult primary tumours: a study of 254 patients, Ann. Surg. 186 (1977) 625-630.
3. C. Parsons, Radiology in oncology, in: R.G. Grainger, D.J. Allison (Eds.), Diagnostic Radiology, vol. 3, Churchill Livingstone, Edinburgh, 1986, pp. 2167-2182.
4. C.A. Perez, W.R. Fair, D.C. Idhe, Carcinoma of prostate, in: V.T. De Vita Jr., S. Hellman, S.A. Rosenberg (Eds.), Cancer - Principles and Practice of Oncology, 3rd edn., JB Lippincott, Philadelphia, PA, 1989, pp. 1023-1058.
5. J.B. Kimmouth, Lymphangiography in man: method outlining lymphatic trunks at operation, Clin. Sci. 11 (1952) 13-20.
6. S.V. Lossef, Complications of lymphography, Semin. Interv. Radiol. 11 (1994) 107-112.
7. H.T. Morehouse, B.A. Thornhill, Nodes or no nodes: CT of adenopathy, CRC Crit. Rev. Diagn. Imaging 25 (1986) 177-207.
8. I.S. Sawczuk, R. de Vere White, R. Palmer Gold, C.A. Olsson, Sensitivity of computed tomography in evaluation of pelvic lymph node metastases from carcinoma of bladder and prostate, Urology 21 (1983) 81-84.
9. T.J. Vogel, M. Bartjes, K. Marzec, Contrast-enhanced lymphography - CT or MR imaging? Acta Radiol. 38 (1997) 47-50.
10. T.C. Case, C.L. Witte, M.H. Witte, E.C. Unger, W.H. Williams, Magnetic-resonance-imaging in human lymphedema - comparison with lymphoscintigraphy, Magn. Reson. Imaging 10 (1992) 549-558.
11. S. Wagner, Benign lymph node hyperplasia and lymph node metastases in rabbits - animal models for magnetic resonance lymphography, Invest. Radiol. 29 (1994) 364-371.
12. M.D. Sombeck, N.P. Mendenhall, J.V. Kaude, G.M. Torres, R.R. Million, Correlation of lymphangiography, computed-tomography, and laparoyomy in the staging of Hodgkin's disease, Int. J. Rad. Oncol. Biol. Phys. 25 (1993) 425-429.
13. R.H. Oyen, H.P. Vanpoppel, F.E. Ameye, W.A. Vandevoorde, A.L. Baert, L.V. Baert, Lymph node staging of localized prostatic-carcinoma with CT and CT-guided fine-needle aspiration biopsy - prospective-study of 285 patients, Radiology 190 (1994) 315-322.
14. B.J. O'Reilly, A. Leung, A. Greco, Magnetic resonance imaging in head and neck, Clin. Otolaryngol. 14 (1989) 67-78.
15. M. Friedman, M.F. Mafee, B.L. Pacella, T.L. Strorigl, L.L. Dew, D.M. Toriumi, Rationale for elective neck dissection in 1990, Laryngoscope 100 (1990) 54-59.
16. P.A. Bottomley, R.E. Hardy, R.E. Argersinger, G. Allen-Moore, A review of 1H nuclear magnetic resonance relaxation in pathology: are T1 and T2 diagnostic? Med. Phys. 14 (1987) 1-37.
17. G.C. Dooms, H. Hricak, M.E. Moseley, K. Bottles, M.R. Fisher, C.B. Higgins, Characterization of lymphadenopathy by magnetic resonance relaxation times: preliminary results, Radiology 155 (1985) 691-697.
18. S.E. Strand, L. Bergqvist, Radiolabeled colloids and macromolecules in the lymphatic system, Crit. Rev. Ther. Drug Carr. Syst. 6 (1989) 211-238.
19. F. Ikomi, G.K. Hanna, G.W. Schimdschonbein, Mechanism of colloidal particle uptake into the lymphatic system -basic study with percutaneous lymphography, Radiology 196 (1995) 107-113.
20. S.M. Moghimi, A.R. Rajabi-Siahboomi, Advanced colloid-based systems for efficient delivery of drugs and diagnostic agents to the lymphatic tissues, Prog. Biophys. Mol. Biol. 65 (1996) 221-249.
21. P.C. Stomper, S.P. Cholewinski, J. Park, S.P. Bakshi, M.P. Barcos, Abdominal staging of thoracic Hodgkin disease -CT lymphangiography Ga-67 scanning correlation, Radiology 187 (1993) 381-386.
22. H.A. Nabi, Antibody imaging in breast cancer, Semin. Nucl. Med. 27 (1997) 30-39.
23. G.D. Robinson Jr., A. Alavi, R. Vaum, M. Staum, Imaging of lymph node uptake after intravenous administration of indium-111 metalloporphyrins, J. Nucl. Med. 27 (1986) 239-242.
24. M. Papisov, R. Weissleder, Drug-delivery to lymphatic tissue, Crit. Rev. Ther. Drug Carr. Syst. 13 (1996) 57-84.
25. R. Weissleder, G. Elizondo, L. Josephson, C.C. Compton, C.J. Fretz, D. Stark, J.T. Ferrucci, Experimental lymph node metastases: enhanced detection with MR lymphography, Radiology 171 (1989) 835-839.
26. R. Weissleder, G. Elizondo, J. Wittenberg, A.S. Lee, L. Josephson, T.J. Brady, Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging, Radiology 175 (1990) 494-498.
27. M. Taupitz, S. Wagner, B. Hamm, D. Dienemann, R. Lawaczeck, K.J. Wolf, MR lymphography using iron-oxide particles - detection of lymph-node metastases in the VX2 rabbit tumor-model, Acta Radiol. 34 (1993) 10-15.
28. R. Wiessleder, J.F. Heautot, B.K. Schaffer, N. Nossiff, M.I. Papisov, A.A. Bogdanov, T.J. Brady, MR lymphography: study of a high lymphotropic agent, Radiology 191 (1994) 225-230.
29. R. Guimaraes, O. Clement, J. Bitton, F. Carnot, G. Frija, MR lymphography with superparamagnetic iron nanoparticles in rats - pathological basis for contrast enhancement, Am. J. Roentgenol. 162 (1994) 201-207.
30. P. Vassallo, C. Matei, W.D.W. Heston, S.J. McLachlan, J.A. Koutcher, R.A. Castellino, AMI-227-enhanced MR lymphography - usefulness for differentiating reactive from tumor-bearing lymph-nodes, Radiology 193 (1994) 501-506.
31. R. Weissleder, A. Bogdanov, E.A. Neuwelt, M. Papisov, Long circulating iron oxides for MR imaging, Adv. Drug Del. Rev. 16 (1995) 321-334.
32. L. Harika, R. Weissleder, K. Poss, C. Zimmer, M.I. Papisov, T.J. Brady, MR lymphography with a lymphotropic T1-type MR contrast agent - GD-DTPA-PGM, Magn. Reson. Med. 33 (1995) 88-92.
33. P.D. Sherve, H.B. Grossman, M.D. Gross, R.L. Wahl, Metastatic prostate-cancer - initial findings of PET with 2-deoxy-2-[F-18] fluoro-D-glucose, Radiology 199 (1996) 751-756.
34. J.W. Bailet, E. Abemajor, B.A. Jabour, R.A. Hawkins, C. Ho, P.H. Ward, Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy, Laryngoscope 102 (1992) 281-288.
35. A. Fasano, Innovative strategies for the oral delivery of drugs and peptides, Trends Biotech. 16 (1998) 152-157.
36. A.I. Sherman, M. Ter-Pogossian, Lymph node concentration of radioactive colloidal gold following interstitial injection, Cancer 6 (1953) 1238-1240.
37. M.N. Croll, L.W. Brady, S. Dadparvar, Implications of lymphoscintigraphy in oncologic practice: principles and differences vis-a-vis other imaging modalities, Semin. Nucl. Med. 13 (1983) 4-8.
38. R.A. Cambria, P. Gloviczki, J.M. Naessens, H.W. Wahner, Noninvasive evaluation of the lymphatic-system with lymphoscintigraphy - a prospective, semiquantitative analysis in 386 extremities, J. Vasc. Surg. 18 (1993) 773-782.
39. K.E. Wells, C.W. Cruse, S. Daniels, C. Berman, J. Norman, D.S. Reintgen, The use of lymphoscintigraphy in melanoma of the head and neck, Plastic Reconstruct. Surg. 93 (1994) 757-761.
40. E.J.T. Rutgers, I.H. Liem, C.A. Hoefnagel, J.A. Vandongen, Lymphoscintigraphy of the axilla with aspecific colloids and monoclonal-antibodies, Breast 4 (1995) 221-222.
41. S.M. Sant, V.J. Tormey, P. Freyne, E.B. Casey, Lymphatic obstruction in rheumatoid-arthritis, Clin. Rheumatol. 14 (1995) 445-450.
42. A.P. Pecking, F.J. Gougeonbertrand, F.M. Lokiec, J.H. Murray, R. Subramanian, A. Boudinet, J.L. Floiras, M.V. Haspel, J.L. Klein, S. Shaban, R.L. Dejager, M.G. Hanna, Radioimmunolymphoscintigraphy in the preoperative staging of primary breast-cancer - a pilot-study using a human monoclonal antibody (LILO-16.88), Int. J. Oncol. 9 (1996) 659-667.
43. M. Weiss, R.G.H. Baumeister, K. Tatsch, K. Hahn, Lymphoscintigraphy for non-invasive long term follow-up of the functional outcome in patients with autologous lymph vessel transplantation, Nuklearmedizin 35 (1996) 236-242.
44. W.D. Perrymore, J.A. Harolds, Technetium-99m-albumin colloid lymphoscintigraphy in postoperative lymphocele, J. Nucl. Med. 37 (1996) 1517-1518.
45. B.A.E. Kapteijn, O.E. Nieweg, R.A.V. Olmos, I.H. Liem, R.K.L.B. Panday, C.A. Hoefnagel, B.B.R. Kroon, Reproducibility of lymphoscintigraphy for lymphatic mapping in cutaneous melanoma, J. Nucl. Med. 37 (1996) 972-975.
46. D.H. Berger, B.W. Feig, D. Podoloff, J. Norman, C.W. Cruse, D.S. Reintgen, M.L. Ross, Lymphoscintigraphy as a predictor of lymphatic drainage from cutaneous melanoma, Ann. Surg. Oncol. 4 (1997) 247-251.
47. R. Pijpers, S. Meijer, O.S. Hoekstra, G.J. Collet, E.F.I. Comans, R.P.A. Boom, P.J. van Diest, J.J. Teule, Impact of lymphoscintigraphy on sentinel node identification with technetium-labeled-human serum albumin, technetium-labeled-sulfur colloid, J. Nucl. Med. 38 (1997) 366-368.
48. A.P. Pecking, R.V. Cluzan, Radionuclide lymphoscintigraphy in limb edema, Med. Nucl. 21 (1997) 77-83.
49. G.T. Werner, W. Gerhards, H. Ingrisch, B. Schutte, Lymphoscintigraphy in paralysed upper limbs, VASA-J. Vascul. Dis. 26 (1997) 25-28.
50. M.K. Nawaz, M.M. Hamad, H.M. Abdeldayem, S. Sadek, B.G.H. Eklof, Tc-99m human serum-albumin lymphoscintigraphy in lymphedema of lower extremities, Clin. Nucl. Med. 15 (1990) 794-799.
51. S.D. Nathanson, L. Nelson, K.C. Karvelis, Rates of flow of technetium 99m-labelled human serum albumin for peripheral injection sites to sentinel lymph nodes, Ann. Surg. Oncol. 4 (1996) 329-335.
52. C. Schatten, M. Barrada, R. Mandeville, H. Enzelsberger, P. Angelberger, K. Czerwenka, E. Kubista, N. Pateisky, Combined use of I-123 labelled BCD-F9 and 4C4 monoclonal antibody with dissimilar specificity for breast cancer -implication for the detection limit of immunolymphoscintigraphy in the assessment of axillary lymph-node metastases, Nucl. Med. Commun. 15 (1994) 422-429.
53. C. Ingvar, K. Norrgren, S.E. Strand, T. Brodin, P.E. Jonsson, H.O. Sjogren, Subcutaneous injection of monoclonal-antibody 96.5 - biokinetics in the nude rat heterotransplanted with malignant melanoma, Acta Oncol. 29 (1990) 1047-1053.
54. J.N. Weinstein, M.A. Steller, A.M. Keenen, D.G. Covell, M.E. Key, S.M. Sieber, R.K. Oldham, K.M. Hwang, R.J. Parker, Monoclonal antibodies in the lymphatics; selective delivery to lymph node metastases of a solid tumor, Science 222 (1983) 423-426.
55. J.N. Weinstein, M.A. Steller, D.G. Covell, O.D. Holton III, A.M. Keenen, S.M. Sieber, R.J. Parker, Monoclonal anti-tumor antibodies in the lymphatics, Cancer Treat. Rep. 68 (1984) 257-264.
56. R.L. Wahl, O. Geatti, M. Liebert, B. Wilson, P. Shreve, B.A. Beers, Kinetic of interstitially administered monoclonal antibodies for purpose of lymphoscintigraphy, J. Nucl. Med. 28 (1987) 1736-1744.
57. M.T. Ercan, H. Kriegel, Autoradiography of lymph nodes with Tc-99m-dextran in rabbits, Nucl. Med. Biol. 19 (1992) 101-103.
58. R.S. Dass, A.K. Singh, U.P.S. Chauhan, Development of a dextran kit for labeling with Tc-99m and its evaluation for lymphoscintigraphy, Nucl. Med. Biol. 20 (1993) 701-706.
59. G. Ege, Lymphoscintigraphy - techniques and applications in the management of breast carcinoma, Semin. Nucl. Med. 13 (1983) 26-34.
60. C. Schatten, N. Pateisky, N. Vara, P. Ehrenbock, P. Angelberger, G. Sivolapenko, A. Epenetos, Lymphoscintigraphy with I-123 labelled epidermal growth factor, Lancet 337 (1991) 395-396.
61. J.C. Pittet, M. Pepin, G. Normier, H. Binz, A. Lepape, Lymphoscintigraphy via the targeting of macrophages with Tc-99m-J001X polygalactoside in a model of pyogranulomas developed in sheep lymph-nodes, Nucl. Med. Biol. 22 (1995) 355-365.
62. S.M. Moghimi, A.E. Hawley, N.M. Christy, T. Gray, L. Illum, S.S. Davis, Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes, FEBS Lett. 344 (1994) 25-30.
63. S.M. Moghimi, I.S. Muir, L. Illum, S.S. Davis, V. Kolb-Bachofen, Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum, Biochim. Biophys. Acta 1179 (1993) 157-165.
64. T.M. Allen, C.B. Hansen, L.S.S. Guo, Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection, Biochim. Biophys. Acta 1150 (1993) 9-16.
65. C. Oussoren, G. Storm, Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: III. Influence of surface modification with poly(ethyleneglycol), Pharm. Res. 14 (1997) 1479-1484.
66. A.E. Hawley, L. Illum, S.S. Davis, Lymph node localization of biodegradable nanospheres surface modified with poloxamer and poloxamine block copolymers, FEBS Lett. 400 (1997) 319-323.
67. A.E. Hawley, L. Illum, S.S. Davis, Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake, Pharm. Res. 14 (1997) 657-661.
68. S.M. Moghimi, Recent developments and limitations of poloxamine-coated long-circulating particles in experimental drug delivery, in: G. Gregoriadis (Ed.), Targeting of Drugs, vol. 6, Plenum Press, New York, (in press).
69. J. Lee, P.A. Martic, J.S. Tan, Protein adsorption on pluronic co-polymer coated polystyrene particles, J. Colloid Interface Sci. 131 (1989) 252-266.
70. S.M. Moghimi, C.J.H. Porter, L. Illum, S.S. Davis, The effect of poloxamer-407 on liposome stability and targeting to bone marrow: comparison with polystyrene particles, Int. J. Pharm. 68 (1991) 121-126.
71. T.M. Allen, C. Hansen, F. Martin, C. Redemann, A. Yau-Young, Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo, Biochim. Biophys. Acta 1066 (1991) 29-36.
72. V.P. Torchilin, M.I. Shtilman, V.S. Trubetskoy, K. Whiteman, A.M. Milstein, Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo, Biochim. Biophys. Acta 1195 (1994) 181-184.
73. M.C. Woodle, C.M. Engbers, S. Zalipsky, New amphipathic polymer lipid conjugates forming long-circulating reticuloendothelial-evading liposomes, Bioconj. Chem. 5 (1994) 493-496.
74. E.R. Wisner, R.W. Katzberg, P.D. Koblik, D.K. Shelton, P.E. Fisher, S.M. Griffey, C.M. Drake, P.P. Harnish, A.R. Vessey, P.J. Haley, P.P. Sarpotdar, N. Rajagopalan, Iodinated nanoparticles for indirect computed tomography lymphography of the carniocervical and thoracic lymph nodes in normal dogs, Acad. Radiol. 1 (1994) 377-384.
75. E.R. Wisner, R.W. Katzberg, S.M. Griffey, C.M. Drake, P.J. Haley, A.R. Vessey, Indirect computed tomography lymphography using iodinated nanoparticles: time and dose response in normal canine lymph nodes, Acad. Radiol. 2 (1995) 985-993.
76. E.R. Wisner, R.W. Katzberg, S.M. Griffey, C.M. Drake, P.J. Haley, D.K. Johnson, A.R. Vessey, Characterization of normal and cancerous lymph nodes on indirect computed tomography lymphographic studies after interstitial injection of iodinated nanoparticles, Acad. Radiol. 3 (1996) S257-S260.
77. E.R. Wisner, R.W. Katzberg, D.P. Link, S.M. Griffey, C.M. Drake, A.R. Vessey, D. Johnson, P.J. Haley, Indirect computed tomography lymphography using iodinated nanoparticles to detect cancerous lymph nodes in a cutaneous melanoma model, Acad. Radiol. 3 (1996) 40-48.
78. G. Hanna, R. Hopkins, K. Flaim, P. Lesse, G. Schmid-Schonbein, G.L. Wolf, Indirect lymphography with perflubron emulsion, Invest. Radiol. 29(Suppl 2) (1994) S33-S35.
79. G.L. Wolf, J. Rogowska, G.K. Hanna, E.F. Halpern, Percutaneous CT lymphography with perflubron - imaging efficacy in rabbits and monkeys, Radiology 191 (1994) 501-505.
80. H. Weissleder, R. Weissleder, Interstitial lymphangiography: initial clinical experience with a dimeric nonionic contrast agent, Radiology 170 (1989) 371-374.
81. E.C. Unger, W.G. Totty, D.M. Neufeld, F.L. Otsuka, W.A. Murphy, M.S. Welch, J.M. Connett, G.W. Philpott, Magnetic resonance imaging using gadolinium labeled monoclonal antibody, Invest. Radiol. 20 (1985) 693-700.
82. L. Harika, R. Weissleder, K. Poss, C. Zimmer, M.I. Papisov, T.J. Brady, MR lymphography with a lymphotropic T1-type MR contrast agent - GD-DTPA-PGM, Magn. Reson. Med. 33 (1995) 88-92.
83. V.S. Trubetskoy, M.D. Frankkamenetsky, K.R. Whiteman, G.L. Wolf, V.P. Torchilin, Stable polymeric micelles -lymphoangiographic contrast-media for gamma-scintigraphy and magnetic-resonance-imaging, Acad. Radiol. 3 (1996) 232-238.
84. H.H. Bengele, S. Plamacci, J. Rogers, C.W. Jung, J. Crenshaw, L. Josphson, Biodistribution of an ultrasmall superparamagnetic iron oxide colloid, BMS 180549, by different routes of administration, Magn. Reson. Imaging 12 (1994) 433-442.
85. Y. Anzai, K.E. Blackwell, S.L. Hirschowitz, J.W. Rogers, Y. Sato, W.T.C. Yuh, V.M. Runge, M.R. Morris, S. McLachlan, R.B. Lufkin, Initial clinical-experience with dextran-coated superparamagnetic iron-oxide for detection of lymph-node metastases in patients with head and neck-cancer, Radiology 192 (1994) 709-715.
86. Y. Anzai, S. McLachlan, M. Morris, R. Saxton, R.B. Lufkin, Dextran-coated superparamagnetic iron-oxide, an MR contrast agent for assessing lymph-node in the head and neck, Am. J. Neuroradiol. 15 (1994) 87-94.
87. T. Tanoura, M. Bernas, A. Darkazanli, E. Elam, E. Unger, M.H. Witte, A. Green, MR lymphography with iron-oxide compound AMI-227 - studies in ferrets with filariasis, Am. J. Roentgenol. 159 (1992) 875-881.
88. G. Frija, O. Clement, O. Leguen, C.A. Cuendo, N. Siauve, S. Benderbous, Experimental investigation of the delivery pathway of ultrasmall superparamagnetic iron-oxide to lymph-nodes, Acad. Radiol. 3(Suppl 2) (1996) S299-S300.
89. A. Moore, R. Weissleder, A. Bogdanov Jr., Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages, J. Magn. Reson. Imaging 7 (1997) 1140-1145.
90. C. Tilcock, E. Unger, P. Cullis, P. MacDougall, Liposomal Gd-DTPA: preparation and characterization of relaxivity, Radiology 171 (1989) 77-80.
91. G.W. Kabalka, M.A. Davis, E. Holmberg, M. Maruyama, L. Huang, Gadolinium-labeled liposomes containing various amphiphilic Gd-DTPA derivatives: targeted MRI contrast enhancement agents for the liver, Magn. Reson. Med. 9 (1991) 373-377.
92. V.P. Torchilin, Liposomes as delivery agents for medical imaging, Mol. Med. Today 2 (1996) 242-249.
93. B. Misselwitz, A. Sachse, Interstitial MR lymphography using Gd-carrying liposomes, Acta Radiol. 38 (1997) 51-55.
94. E.R. Wisner, K.L. AhoSharon, M.J. Bennett, S.G. Penn, C.B. Lebrilla, M.H. Nantz, A modular lymphographic magnetic resonance imaging contrast agent: contrast enhancement with DNA transfection potential, J. Med. Chem. 40 (1997) 3992-3996.
95. A.A. Bogdanov, C. Martin, R. Weissleder, T.J. Brady, Trapping of dextran-coated colloids in liposomes by transient binding to aminophospholipids - preparation of ferrosomes, Biochim. Biophys. Acta 1193 (1994) 212-218.
96. T.C. Yeh, W. Zhang, S.T. Ildstad, C. Ho, Intracellular labeling of T-cells with superparamagnetic contrast agents, Magn. Reson. Med. 30 (1993) 617-625.
97. T.C. Yeh, W. Zhang, S.T. Ildstad, C. Ho, In vivo dynamic MR tracking of rat T-cells labeled with superparamagnetic iron-oxide particles, Magn. Reson. Med. 33 (1995) 200-208.
98. V. Elste, S. Wagner, M. Taupitz, D. Pfefferer, M. Kresse, B. Hamm, R. Berg, K.J. Wolf, W. Semmler, Magnetic-resonance lymphography in rats: effects of muscular activity and heperthermia on the lymph-node uptake of intravenously injected superparamagnetic iron-oxide particles, Acad. Radiol. 3 (1996) 660-666.
99. A.O. Anderson, N.D. Anderson, Studies on the structure and permeability of the microvasculature in normal rat lymph nodes, Am. J. Pathol. 80 (1975) 387-418.
100. N.D. Anderson, A.O. Anderson, R.G. Wyllie, Specialized structure and metabolic activities of high endothelial venules in rat lymphatic tissues, Immunology 31 (1976) 455-473.
101. J.M. Rogers, J. Lewis, L. Josephson, Visualization of superior mesenteric lymph-nodes by the combined oral and intravenous administration of the ultrasmall superparamagnetic iron oxide, AMI-227, Magn. Reson. Imaging 12 (1994) 1161-1165.
102. J. Rosenecker, W. Zhang, K. Hong, J. Lausier, P. Geppetti, S. Yoshihara, D. Paphadjopoulos, J.A. Nadel, Increased liposome extravasation in selected tissues - effect of substance-P, Proc. Natl. Acad. Sci. USA 93 (1996) 7236-7241.
103. L.E. Gerlowski, R.K. Jain, Microvascular permeability of normal and neoplastic tissues, Microvasc. Res. 31 (1986) 288-305.
104. A. Muller, X. Zhang, H. Wang, R. Lawaczeck, H.J. Weinmann, Investigation of mechanisms influencing the accumulation of ultrasmall superparamagnetic iron oxide particles in lymph nodes, Invest. Radiol. 30 (1995) 98-103.
105. J. Victor, The metabolism of single normal mouse lymph nodes, Am. J. Physiol. 111 (1935) 477-482.
106. O. Lundgren, I. Wallenten, Local chemical and nervous control of consecutive vascular sections in the mesenteric lymph nodes of the cat, Angiolica 1 (1964) 284-296.
107. M.H. Claesson, O. Jorgensen, C. Ropke, Light and electron microscopic studies of the paracorticol post-capillary high-endothelial venules, Z. Zellforsch. Mikrosk. Anat. 119 (1971) 95-102.
108. S.M. Moghimi, H.M. Patel, Serum-mediated recognition of liposomes by phagocytes of the reticuloendothelial system - the concept of tissue specificity. Adv. Drug Del. Rev. (1998) (in press).
109. L. Harika, R. Weissleder, K. Poss, M.I. Papisov, Macromolecular intravenous contrast agent for MR lymphography - characterization and efficacy studies, Radiology 198 (1996) 365-370.
110. Y. Anzai, M.R. Prince, Iron oxide-enhanced MR lymphography: the evaluation of cervical lymph node metastases in head and neck cancer, J. Magn. Reson. Imaging 7 (1997) 75-81.
111. S.J. McLachlan, M.R. Morris, M.A. Lucas, B.A. Fisco, M.N. Eakins, D.R. Fowler, R.B. Scheetz, A.Y. Olukotun, Phase I clinical evaluation of a new iron oxide MR contrast agent, J. Magn. Reson. Imaging 4 (1994) 301-307.
112. M.G. Harisinghani, S. Saini, G.J. Slater, M.D. Schnall, M.D. Rifkin, MR imaging of pelvic lymph nodes in primary pelvic carcinoma with ultrasmall superparamagnetic iron oxide (Combidex): preliminary observations, J. Magn. Reson. Imaging 7 (1997) 161-163.
113. J.P. Laissy, P. Gay-Depassier, P. Soyer, M.C. Dombart, G. Murciano, A. Sautet, M. Aubier, Y. Menu, Enlarged mediastinal lymph nodes in bronchogenic carcinoma: assessment with dynamic contrast-enhanced MR imaging, Radiology 191 (1994) 263-267.
114. S. Lamer, R. Sigal, N. Lassau, J. Bosq, F. Frouin, M. Di Paola, G. Mamelle, J. Leclere, J. Bittoun, R. Di Paola, Radiologic assessment of intranodal vascularity in head and neck squamous cell carcinoma, Invest. Radiol. 31 (1996) 673-679.
115. D.G. Jamieson, J.H. Greenberg, Positron emission tomography of the brain, Comput. Med. Imag. Graph. 13 (1989) 61-79.